Evaluation of the effects of antioxidant treatment on sperm parameters and pregnancy rates in infertile patients after varicocelectomy: a randomized controlled trial

International Journal of Impotence Research

Volumn 31, Issue 6, 2019, Pages 424-431

  Kızılay, Fuat ^a   Altay, Barış ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CARNITINE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; INFERTILITY; MAJOR CLINICAL STUDY; MALE; MALE GENITAL TRACT PARAMETERS; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PREGNANCY RATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEMEN VOLUME; SPERM MORPHOLOGY; SPERM NUMBER; SPERM PARAMETERS; SPERMATOZOON ABNORMALITY; SPERMATOZOON COUNT; SPERMATOZOON DENSITY; SPERMATOZOON MOTILITY; TESTIS SIZE; VARICOCELECTOMY; COMPLICATION; DRUG EFFECT; FEMALE; MALE INFERTILITY; PREGNANCY; SPERMATOZOON; TREATMENT OUTCOME; VARICOCELE; YOUNG ADULT;

ADULT; ANTIOXIDANTS; FEMALE; HUMANS; INFERTILITY, MALE; MALE; POSTOPERATIVE PERIOD; PREGNANCY; PREGNANCY RATE; SPERM COUNT; SPERM MOTILITY; SPERMATOZOA; TREATMENT OUTCOME; VARICOCELE; YOUNG ADULT;

EID: 85060221553     PISSN: 09559930     EISSN: 14765489     Source Type: Journal    
DOI: 10.1038/s41443-018-0109-4     Document Type: Article

References (36)

1. Rowe PJ, Comhaire FH, Hargreave TB, Mahmoud AM. WHO manual for the standardized investigation and diagnosis of the infertile male. Cambridge University Press, 2000.
2. Greenhall E, Vessey M. The prevalence of subfertility: a review of the current confusion and a report of two new studies. Fertil Steril. 1990;54:978–83.
3. Alsaikhan B, Alrabeeah K, Delouya G, Zini A. Epidemiology of varicocele. Asian J Androl. 2016;18:179–81.
4. Shiraishi K, Matsuyama H, Takihara H. Pathophysiology of varicocele in male infertility in the era of assisted reproductive technology. Int J Urol. 2012;19:538–50.
5. Hamada A, Esteves SC, Agarwal A. Insight into oxidative stress in varicocele-associated male infertility: part 2. Nat Rev Urol. 2013;10:26.
6. Agarwal A, Deepinder F, Cocuzza M, Agarwal R, Short RA, Sabanegh E, et al. Efficacy of varicocelectomy in improving semen parameters: new meta-analytical approach. Urology. 2007;70:532–8.
7. Baazeem A, Boman JM, Libman J, Jarvi K, Zini A. Microsurgical varicocelectomy for infertile men with oligospermia: differential effect of bilateral and unilateral varicocele on pregnancy outcomes. BJU Int. 2009;104:524–8.
8. Zini A, Dohle G. Are varicoceles associated with increased deoxyribonucleic acid fragmentation? Fertil Steril. 2011;96:1283–7.
9. Agarwal A, Hamada A, Esteves SC. Insight into oxidative stress in varicocele-associated male infertility: part 1. Nat Rev Urol. 2012;9:678.
10. Garg H, Kumar R. An update on the role of medical treatment including antioxidant therapy in varicocele. Asian J Androl. 2016;18:222–8.
11. Agarwal A, Mulgund A, Alshahrani S, Assidi M, Abuzenadah AM, Sharma R, et al. Reactive oxygen species and sperm DNA damage in infertile men presenting with low level leukocytospermia. Reprod Biol Endocrinol. 2014;12:126.
12. Bonanno O, Romeo G, Asero P, Pezzino FM, Castiglione R, Burrello, et al. Sperm of patients with severe asthenozoospermia show biochemical, molecular, and genomic alterations. Reproduction. 2016;152:695–704.
13. Özkan K, Boran C, Kilinc M, Garipardic M, Kurutaş E. The effect of zinc aspartate pretreatment on ischemia-reperfusion injury and early changes of blood and tissue antioxidant enzyme activities after unilateral testicular torsion-detorsion. J Pediatr Surg. 2004;39:91–95.
14. Paolicchi A, Pezzini A, Saviozzi M, Piaggi S, Andreuccetti M, Chieli E, et al. Localization of a GSH-dependent dehydroascorbate reductase in rat tissues and subcellular fractions. Arch Biochem Biophys. 1996;333:489–95.
15. Yoganathan T, Eskild W, Hansson V. Investigation of detoxification capacity of rat testicular germ cells and Sertoli cells. Free Radic Biol Med. 1989;7:355–9.
16. Vicari E, Calogero A. Effects of treatment with carnitines in infertile patients with prostato-vesiculo-epididymitis. Hum Reprod. 2001;16:2338–42.
17. World Health Organization. WHO laboratory manual for the examination and processing of human semen. 2010.
18. Baazeem A, Belzile E, Ciampi A, Dohle G, Jarvi K, Salonia A, et al. Varicocele and male factor infertility treatment: a new meta-analysis and review of the role of varicocele repair. Eur Urol. 2011;60:796–808.
19. Brasch JG, Rawlins R, Tarchala S, Radwanska E. The relationship between total motile sperm count and the successof intrauterine insemination. Fertil Steril. 1994;62:150–4.
20. Dada R, Shamsi MB, Venkatesh S, Gupta NP, Kumar R. Attenuation of oxidative stress & DNA damage in varicocelectomy: implications in infertility management. Indian J Med Res. 2010;132:728–30.
21. Zini A, Buckspan M, Jamal M, Jarvi K. Effect of varicocelectomy on the abnormal retention of residual cytoplasm by human spermatozoa. Hum Reprod. 1999;14:1791–3.
22. Gamidov SI, Ovchinnikov RI, Popova AY, Avakyan AY, Sukhikh GT. [Adjuvant antioxidant therapy in varicocele infertility]. Urologiia. 2017;2:64–72.
23. Busetto GM, Agarwal A, Virmani A, Antonini G, Ragonesi G, Del Giudice F et al. Effect of metabolic and antioxidant supplementation on sperm parameters in oligo-astheno-teratozoospermia, with and without varicocele: a double-blind placebo-controlled study. Andrologia 2018; 50: 10.1111/and.12927.
24. Badr YAA, Sepehran E, Del Azar A, Sadeghi H, Nouri M. The effect of saffron on semen analysis in infertile men with clinical varicocele after varicocelectomy. Nephro-Urology Monthly 2017; 9:e59939.
25. Lu XL, Liu JJ, Li JT, Yang QA, Zhang JM. Melatonin therapy adds extra benefit to varicecelectomy in terms of sperm parameters, hormonal profile and total antioxidant capacity: a placebo-controlled, double-blind trial. Andrologia 2018;50:e13033.
26. Barekat F, Tavalaee M, Deemeh MR, Bahreinian M, Azadi L, Abbasi H, et al. A preliminary study: N-acetyl-L-cysteine improves semen quality following varicocelectomy. Int J Fertil Steril. 2016;10:120–6.
27. Chen YW, Niu YH, Wang DQ, Li H, Pokhrel G, Xu H, et al. Effect of adjuvant drug therapy after varicocelectomy on fertility outcome in males with varicocele-associated infertility: systematic review and meta-analysis. Andrologia. 2018;50:e13070.
28. Sofimajidpour H, Ghaderi E, Ganji O. Comparison of the effects of varicocelectomy and oral L-carnitine on sperm parameters in infertile men with varicocele. J Clin Diagn Res. 2016;10:PC07–10.
29. Sigman M, Glass S, Campagnone J, Pryor JL. Carnitine for the treatment of idiopathic asthenospermia: a randomized, double-blind, placebo-controlled trial. Fertil Steril. 2006;85:1409–14.
30. Lenzi A, Sgro P, Salacone P, Paoli D, Gilio B, Lombardo F, et al. A placebo-controlled double-blind randomized trial of the use of combined l-carnitine and l-acetyl-carnitine treatment in men with asthenozoospermia. Fertil Steril. 2004;81:1578–84.
31. Festa R, Giacchi E, Raimondo S, Tiano L, Zuccarelli P, Silvestrini A, et al. Coenzyme Q10 supplementation in infertile men with low-grade varicocele: an open, uncontrolled pilot study. Andrologia. 2014;46:805–7.
32. Nadjarzadeh A, Sadeghi M, Amirjannati N, Vafa M, Motevalian S, Gohari M, et al. Coenzyme Q10 improves seminal oxidative defense but does not affect on semen parameters in idiopathic oligoasthenoteratozoospermia: a randomized double-blind, placebo controlled trial. J Endocrinol Invest. 2011;34:e224–e228.
33. Aydos OS, Yükselten Y, Kaplan F, Sunguroğlu A, Aydos K. Analysis of the correlation between sperm DNA integrity and conventional semen parameters in infertile men. Turk J Urol. 2015;41:191.
34. Foresta C, Flohé L, Garolla A, Roveri A, Ursini F, Maiorino M. Male fertility is linked to the selenoprotein phospholipid hydroperoxide glutathione peroxidase. Biol Reprod. 2002;67:967–71.
35. Ko EY, Sabanegh ES. The role of nutraceuticals in male fertility. Urol Clin North Am. 2014;41:181–93.
36. Kothari S, Thompson A, Agarwal A, du Plessis SS. Free radicals: their beneficial and detrimental effects on sperm function. 2010;48:425–35.